Voloridge Investment Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-492,430
| Closed | -$13.7M | – | 1016 |
|
|
2025
Q4 | $13.7M | Sell |
492,430
-767,581
| -61% | -$19.6M | 0.05% | 486 |
|
|
2025
Q3 | $30.6M | Buy |
1,260,011
+128,218
| +11% | +$2.55M | 0.1% | 237 |
|
|
2025
Q2 | $19.3M | Buy |
1,131,793
+816,357
| +259% | +$14.2M | 0.07% | 334 |
|
|
2025
Q1 | $6.16M | Sell |
315,436
-97,973
| -24% | -$2.57M | 0.02% | 726 |
|
|
2024
Q4 | $10.3M | Sell |
413,409
-50,253
| -11% | -$1.28M | 0.04% | 564 |
|
|
2024
Q3 | $11.4M | Buy |
463,662
+80,667
| +21% | +$2.08M | 0.04% | 546 |
|
|
2024
Q2 | $8.97M | Buy |
382,995
+146,608
| +62% | +$3.6M | 0.03% | 589 |
|
|
2024
Q1 | $7.81M | Buy |
236,387
+78,139
| +49% | +$2.43M | 0.03% | 543 |
|
|
2023
Q4 | $4.31M | Buy |
+158,248
| New | +$3.93M | 0.02% | 662 |
|
|
2023
Q3 | – | Sell |
-29,161
| Closed | -$931K | – | 1380 |
|
|
2023
Q2 | $931K | Sell |
29,161
-29,655
| -50% | -$962K | ﹤0.01% | 1132 |
|
|
2023
Q1 | $1.8M | Buy |
58,816
+12,820
| +28% | +$506K | 0.01% | 1000 |
|
|
2022
Q4 | $1.8M | Sell |
45,996
-168,224
| -79% | -$7.53M | 0.01% | 989 |
|
|
2022
Q3 | $10.2M | Sell |
214,220
-112,274
| -34% | -$6.4M | 0.06% | 435 |
|
|
2022
Q2 | $12.6M | Buy |
326,494
+248,897
| +321% | +$9.89M | 0.07% | 374 |
|
|
2022
Q1 | $4.45M | Buy |
77,597
+61,595
| +385% | +$4.04M | 0.03% | 677 |
|
|
2021
Q4 | $1.27M | Buy |
16,002
+3,592
| +29% | +$308K | 0.01% | 1203 |
|
|
2021
Q3 | $1.08M | Sell |
12,410
-222,044
| -95% | -$22.3M | 0.01% | 1257 |
|
|
2021
Q2 | $30.2M | Sell |
234,454
-10,187
| -4% | -$812K | 0.21% | 115 |
|
|
2021
Q1 | $19.6M | Buy |
244,641
+67,793
| +38% | +$6.45M | 0.14% | 188 |
|
|
2020
Q4 | $14.4M | Buy |
+176,848
| New | +$8.7M | 0.12% | 204 |
|
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
